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induce graft survival. Furthermore, when splenocytes from CBK mice (an MHC class I, K b , transgenic strain [H2 k +K b ] in the context of CBA 4 ) were used for oral pretreatment in combination with anti-CD4, all C57BL/10 grafts survived for more than 100 days (Table 1) . Therefore, oral exposure to a single donor alloantigen K b was sufficient to induce unresponsiveness to a fully allogeneic C57BL/10 (H2b: K b +D b +L b +IA b ) cardiac graft, which can be explained by the linked suppression. 4, 5 On the other hand, we have already shown that orally delivered cells are degraded and that alloantigens may be presented on MHC molecules of the recipient (ie, indirect allorecognition). 2 The direct antigen recognition, in which recipient T cells directly recognize MHC molecules on donor cells, mainly generates acute rejection of a fully MHCmismatched graft. Taken together, these findings suggest that the linked suppression through the indirect pathway is involved in survival of cardiac allografts in this model. Therefore, we speculated that not only an MHC molecule but also a foreign protein antigen can induce graft prolongation when delivered orally with anti-CD4 and presented at the time of transplantation. In an attempt to confirm this hypothesis, we fed CBA mice with 50 mg of OVA (day -7) in the presence of anti-CD4 (days -8 and -7). All C57BL/10 grafts survived for more than 50 days when 50 mg of OVA was again fed at the time of transplantation (MST >100 days, Table 1 ). By contrast, mice only receiving OVA at the time of pretreatment rejected their grafts within 50 days (MST = 24 days, Table 1 ), demonstrating that a foreign peptide can induce unresponsiveness to MHC molecules when pretreated orally with anti-CD4 and presented at the same time of transplantation.
In this study we can clearly demonstrate that importance of the alimentary tract to induce unresponsiveness against fully allogeneic grafts with an MHC molecule or a foreign peptide in combination with nondepleting anti-CD4. This observation will be able to apply clinical manipulation to induce operational tolerance against allogeneic cardiac grafts. 1 Recipients pretreated with oral administration of a common MHC antigen in the presence of anti-CD4 may be tolerant to an allogeneic organ sharing the MHC antigen, even if the other MHC antigens are mismatched. 2 A recipient pretreated with oral administration of a foreign antigen in combination with anti-CD4 may accept any allogeneic organs when the foreign antigen coexists at the time of transplantation.
